Bausch Health Companies Inc (BHC)
8.18
-0.01
(-0.12%)
USD |
NYSE |
Nov 21, 16:00
8.185
0.00 (0.00%)
Pre-Market: 20:00
Bausch Health Enterprise Value: 24.73B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 24.73B |
| November 20, 2024 | 24.73B |
| November 19, 2024 | 24.73B |
| November 18, 2024 | 24.80B |
| November 15, 2024 | 24.84B |
| November 14, 2024 | 24.94B |
| November 13, 2024 | 24.95B |
| November 12, 2024 | 25.08B |
| November 11, 2024 | 25.16B |
| November 08, 2024 | 25.16B |
| November 07, 2024 | 25.18B |
| November 06, 2024 | 25.21B |
| November 05, 2024 | 25.28B |
| November 04, 2024 | 25.13B |
| November 01, 2024 | 25.32B |
| October 31, 2024 | 25.10B |
| October 30, 2024 | 24.72B |
| October 29, 2024 | 24.72B |
| October 28, 2024 | 24.73B |
| October 25, 2024 | 24.68B |
| October 24, 2024 | 24.71B |
| October 23, 2024 | 24.69B |
| October 22, 2024 | 24.70B |
| October 21, 2024 | 24.72B |
| October 18, 2024 | 24.72B |
| Date | Value |
|---|---|
| October 17, 2024 | 24.79B |
| October 16, 2024 | 24.83B |
| October 15, 2024 | 24.80B |
| October 14, 2024 | 24.75B |
| October 11, 2024 | 24.64B |
| October 10, 2024 | 24.70B |
| October 09, 2024 | 24.64B |
| October 08, 2024 | 24.68B |
| October 07, 2024 | 24.72B |
| October 04, 2024 | 24.78B |
| October 03, 2024 | 24.76B |
| October 02, 2024 | 24.72B |
| October 01, 2024 | 24.76B |
| September 30, 2024 | 24.72B |
| September 27, 2024 | 25.05B |
| September 26, 2024 | 24.99B |
| September 25, 2024 | 24.96B |
| September 24, 2024 | 24.98B |
| September 23, 2024 | 24.95B |
| September 20, 2024 | 24.96B |
| September 19, 2024 | 25.02B |
| September 18, 2024 | 24.96B |
| September 17, 2024 | 24.65B |
| September 16, 2024 | 24.58B |
| September 13, 2024 | 24.33B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.16B
Minimum
May 12 2023
35.62B
Maximum
Mar 11 2021
28.00B
Average
25.90B
Median
Mar 20 2024
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 906.94M |
| Edesa Biotech Inc | 4.811M |
| Lexaria Bioscience Corp | 25.27M |
| Xenon Pharmaceuticals Inc | 2.380B |
| ESSA Pharma Inc | -52.60M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -85.00M |
| Revenue (Quarterly) | 2.51B |
| Total Expenses (Quarterly) | 1.981B |
| EPS Diluted (Quarterly) | -0.23 |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -3.39% |
| Earnings Yield | -5.87% |
| Operating Earnings Yield | 58.22% |
| Normalized Earnings Yield | 4.577 |